Skip to content

Clinical trials

Phase 1/2 Central Nervous System Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
20014
20023
20033
20044
20054
20062
20072
20081
20092
20104
20111
20121
20142
20162
20173
20181
20191
20213
20223
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Terminated8
Recruiting7
Active, not recruiting6
Unknown status4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8
New Approaches to Brain Tumor Therapy Consortium7
Memorial Sloan Kettering Cancer Center5
Duke University4
Radiation Therapy Oncology Group4
National Cancer Institute (NCI)3
Alliance for Clinical Trials in Oncology2
Eli Lilly and Company2
Hoffmann-La Roche2
Jonsson Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms69
Glioblastoma41
Brain Neoplasms40
Gliosarcoma35
Astrocytoma29
Glioma23
Oligodendroglioma22
Neoplasms9
Medulloblastoma8
Neoplasm Metastasis7

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.